Go to Client Portal

A Practical Guide to Writing Summaries of Safety and Clinical Performance

Access On-Demand Webinar Here

When it comes to medical documentation, it is important for the inclusion of complex technical information to be easily comprehended by patients or other lay-persons, who are often the intended audience. This is especially true for EU Medical Device Regulation (MDR) Summaries of Safety and Clinical Performance (SSCPs), and is considered a key attribute.

Join NAMSA for an engaging and practical webinar, led by one of our former Notified Body auditors, where we will review MDR SSCPs from the Notified Body perspective with a focus on demonstrating how to write clear, concise and informative SSCPs.

Attendees of this webinar can expect to learn how to:

  • Summarize clinical data without the SSCP being a re-write of the Clinical Evaluation Report (CER)
  • Tackle clinical gaps
  • Translate the regulatory requirements of MDCG 2019-9 into meaningful clinical communication – for both the clinician and the lay-person
  • Ensure the SSCP remains manageable and readable while being continually updated with Post Market Clinical Follow-Up (PMCF) data
  • Understand the practicalities and complexities when authoring SSCPs
  • Understand the practical routes for lay-person assessment
  • Maintain SSCPs as they grow year on year with PMCF data


*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.